顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバル組換え抗血友病グロブリン市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバル組換え抗血友病グロブリン市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Recombinant Antihemophilic Globulin - Global Top Players Market Share and Ranking 2026
  • レポートID：
    223933
  • 発表時期：
    2026-03-03
  • レポート形式：
    PDF
  • 産業カテゴリー：
    薬品及びサプリメント
  • レポート言語：
    英語、日本語
  • ページ数：
    113
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の組換え抗血友病グロブリン市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から組換え抗血友病グロブリン市場を分析し、需要構造と成長特性を明確化します。
組換え抗血友病グロブリン市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、組換え抗血友病グロブリンに関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要組換え抗血友病グロブリン市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは組換え抗血友病グロブリン市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
組換え抗血友病グロブリン市場の主要企業には以下が含まれます：
Shire (Baxter)
Bayer Healthcare
CSL
Pfizer
Grifols
Biogen
Octapharma
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Baxalta 

製品別
Baikoc
Afstyla
Altuviiio 

アプリケーション別
Clinical Treatment
Drug Research
Others 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
組換え抗血友病グロブリン市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
組換え抗血友病グロブリン市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に組換え抗血友病グロブリン市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に組換え抗血友病グロブリン市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、組換え抗血友病グロブリン市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、組換え抗血友病グロブリン市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
組換え抗血友病グロブリン市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 組換え抗血友病グロブリン市場の全体像と成長見通し
組換え抗血友病グロブリン市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が組換え抗血友病グロブリン市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
組換え抗血友病グロブリン産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
組換え抗血友病グロブリン市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から組換え抗血友病グロブリン市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
組換え抗血友病グロブリン市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
組換え抗血友病グロブリン市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Recombinant Antihemophilic Globulin should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.
The recombinant antihemophilic globulin is a drug synthesized by gene recombination technology, which is used to treat patients with hemophilia A. Hemophilia A is an inherited bleeding disorder caused by deficiency or dysfunction of clotting factor VIII.

The recombinant antihemophilic globulin is a synthetic form of factor VIII that functions similarly to the human-produced clotting factor VIII. It helps hemophilia A patients restore normal coagulation function and prevent or treat bleeding episodes by supplementing deficient coagulation factor VIII. The preparation process of the recombinant antihemophilic globulin includes the following steps: gene cloning, expression vector construction, cell culture and expression, purification and preparation. It has the characteristics of high efficiency, safety and stability, can effectively control and prevent bleeding, and improve the quality of life of hemophilia patients.

This report studies and analyses global Recombinant Antihemophilic Globulin status and future trends, helps the client to determine the Recombinant Antihemophilic Globulin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Recombinant Antihemophilic Globulin, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Recombinant Antihemophilic Globulin market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (Units)
(2) Global Recombinant Antihemophilic Globulin sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Units)
(3) Japan Recombinant Antihemophilic Globulin sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Units)
(4) Global Recombinant Antihemophilic Globulin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Recombinant Antihemophilic Globulin key producing regions, capacity, production, and year over year growth
(6) Recombinant Antihemophilic Globulin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Shire (Baxter)
    Bayer Healthcare
    CSL
    Pfizer
    Grifols
    Biogen
    Octapharma
    Novo Nordisk
    Greencross
    Kedrion
    BPL
    Hualan Bio
    RAAS
    Baxalta

Market segment by Type, covers
    Baikoc
    Afstyla
    Altuviiio

Market segment by Application, can be divided into
    Clinical Treatment
    Drug Research
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Recombinant Antihemophilic Globulin product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Recombinant Antihemophilic Globulin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Recombinant Antihemophilic Globulin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Recombinant Antihemophilic Globulin, percent & CAGR, 2021-2032
Chapter 5: Recombinant Antihemophilic Globulin industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Recombinant Antihemophilic Globulin Definition
    1.2 Global Recombinant Antihemophilic Globulin Market Size and Forecast
        1.2.1 By Consumption Value, Global Recombinant Antihemophilic Globulin Market Size, 2021-2032
        1.2.2 By Sales Quantity, Global Recombinant Antihemophilic Globulin Market Size, 2021-2032
        1.2.3 Global Recombinant Antihemophilic Globulin Average Selling Price (ASP), 2021-2032
    1.3 Japan Recombinant Antihemophilic Globulin Market Size and Forecast
        1.3.1 By Consumption Value, Japan Recombinant Antihemophilic Globulin Market Size, 2021-2032
        1.3.2 By Sales Quantity, Japan Recombinant Antihemophilic Globulin Market Size, 2021-2032
        1.3.3 Japan Recombinant Antihemophilic Globulin Average Selling Price (ASP), 2021-2032
    1.4 Share of Japan Recombinant Antihemophilic Globulin Market with Respect to the Global Market
        1.4.1 By Consumption Value, Japan Recombinant Antihemophilic Globulin Market Share in Global, 2021-2032
        1.4.2 By Sales Quantity, Japan Recombinant Antihemophilic Globulin Market Share in Global, 2021-2032
        1.4.3 Recombinant Antihemophilic Globulin Market Size: Japan VS Global, 2021-2032
    1.5 Recombinant Antihemophilic Globulin Market Dynamics
        1.5.1 Recombinant Antihemophilic Globulin Market Drivers
        1.5.2 Recombinant Antihemophilic Globulin Market Restraints
        1.5.3 Recombinant Antihemophilic Globulin Industry Trends
        1.5.4 Recombinant Antihemophilic Globulin Industry Policy
2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Recombinant Antihemophilic Globulin, Global Market Share by Company, 2021-2026
    2.2 By Sales Quantity of Recombinant Antihemophilic Globulin, Global Market Share by Company, 2021-2026
    2.3 Recombinant Antihemophilic Globulin Average Selling Price (ASP) by Company, 2021-2026
    2.4 Global Recombinant Antihemophilic Globulin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Recombinant Antihemophilic Globulin Concentration Ratio
    2.6 Global Recombinant Antihemophilic Globulin Mergers & Acquisitions, Expansion Plans
    2.7 Global Recombinant Antihemophilic Globulin Manufacturers Product Type
    2.8 Head Office and Recombinant Antihemophilic Globulin Production Site of Key Manufacturer
    2.9 Recombinant Antihemophilic Globulin Capacity of Major Manufacturers and Future Plan
3 Japan Leading Manufacturers and Market Share
    3.1 By Revenue of Recombinant Antihemophilic Globulin, Japan Market Share by Company, 2021-2026
    3.2 By Sales Quantity of Recombinant Antihemophilic Globulin, Japan Market Share by Company, 2021-2026
    3.3 Japan Recombinant Antihemophilic Globulin Recombinant Antihemophilic Globulin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
    4.1 Global Recombinant Antihemophilic Globulin Capacity, Output and Capacity Utilization, 2021-2032
    4.2 Global Recombinant Antihemophilic Globulin Capacity by Region
    4.3 Global Recombinant Antihemophilic Globulin Production & Forecast by Region, 2021 VS 2025 VS 2032
    4.4 Global Recombinant Antihemophilic Globulin Production by Region, 2021-2032
    4.5 Global Recombinant Antihemophilic Globulin Production Market Share & Forecast by Region, 2021-2032
5 Industry Chain Analysis
    5.1 Recombinant Antihemophilic Globulin Industry Chain
    5.2 Recombinant Antihemophilic Globulin Upstream Analysis
        5.2.1 Recombinant Antihemophilic Globulin Core Raw Materials
        5.2.2 Main Manufacturers of Recombinant Antihemophilic Globulin Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Recombinant Antihemophilic Globulin Production Mode
    5.6 Recombinant Antihemophilic Globulin Procurement Model
    5.7 Recombinant Antihemophilic Globulin Industry Sales Model and Sales Channels
        5.7.1 Recombinant Antihemophilic Globulin Sales Model
        5.7.2 Recombinant Antihemophilic Globulin Typical Distributors
6 Sights by Type
    6.1 Recombinant Antihemophilic Globulin Classification by Type
        6.1.1 Baikoc
        6.1.2 Afstyla
        6.1.3 Altuviiio
    6.2 by Type, Global Recombinant Antihemophilic Globulin Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Type, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032
    6.4 by Type, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032
    6.5 by Type, Global Recombinant Antihemophilic Globulin Average Selling Price (ASP), 2021-2032
7 Sights by Application
    7.1 Recombinant Antihemophilic Globulin Segment by Application
        7.1.1 Clinical Treatment
        7.1.2 Drug Research
        7.1.3 Others
    7.2 by Application, Global Recombinant Antihemophilic Globulin Consumption Value & CAGR, 2021 VS 2025 VS 2032
    7.3 by Application, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032
    7.4 by Application, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032
    7.5 by Application, Global Recombinant Antihemophilic Globulin Price, 2021-2032
8 Sales Sights by Region
    8.1 By Region, Global Recombinant Antihemophilic Globulin Consumption Value, 2021 VS 2025 VS 2032
    8.2 By Region, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032
    8.3 By Region, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032
    8.4 North America
        8.4.1 North America Recombinant Antihemophilic Globulin Market Size & Forecasts, 2021-2032
        8.4.2 By Country, North America Recombinant Antihemophilic Globulin Market Size Market Share
    8.5 Europe
        8.5.1 Europe Recombinant Antihemophilic Globulin Market Size & Forecasts, 2021-2032
        8.5.2 By Country, Europe Recombinant Antihemophilic Globulin Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Recombinant Antihemophilic Globulin Market Size & Forecasts, 2021-2032
        8.6.2 By Country/Region, Asia Pacific Recombinant Antihemophilic Globulin Market Size Market Share
    8.7 South America
        8.7.1 South America Recombinant Antihemophilic Globulin Market Size & Forecasts, 2021-2032
        8.7.2 By Country, South America Recombinant Antihemophilic Globulin Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global Recombinant Antihemophilic Globulin Market Size & CAGR, 2021 VS 2025 VS 2032
    9.2 By Country, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032
    9.3 By Country, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032
    9.4 United States
        9.4.1 United States Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.4.2 by Type, United States Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.4.3 by Application, United States Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.5 Europe
        9.5.1 Europe Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.5.2 by Type, Europe Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.5.3 by Application, Europe Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.6 China
        9.6.1 China Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.6.2 by Type, China Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.6.3 by Application, China Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.7 Japan
        9.7.1 Japan Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.7.2 by Type, Japan Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.7.3 by Application, Japan Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.8 South Korea
        9.8.1 South Korea Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.8.2 by Type, South Korea Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.8.3 by Application, South Korea Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.9 Southeast Asia
        9.9.1 Southeast Asia Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.9.2 by Type, Southeast Asia Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.9.3 by Application, Southeast Asia Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.10 India
        9.10.1 India Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.10.2 by Type, India Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.10.3 by Application, India Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Recombinant Antihemophilic Globulin Market Size, 2021-2032
        9.11.2 by Type, Middle East & Africa Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
        9.11.3 by Application, Middle East & Africa Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
10 Manufacturers Profile
    10.1 Shire (Baxter)
        10.1.1 Shire (Baxter) Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Shire (Baxter) Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.1.3 Shire (Baxter) Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.1.4 Shire (Baxter) Company Profile and Main Business
        10.1.5 Shire (Baxter) Recent Developments
    10.2 Bayer Healthcare
        10.2.1 Bayer Healthcare Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Bayer Healthcare Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.2.3 Bayer Healthcare Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.2.4 Bayer Healthcare Company Profile and Main Business
        10.2.5 Bayer Healthcare Recent Developments
    10.3 CSL
        10.3.1 CSL Company Information, Head Office, Market Area, and Industry Position
        10.3.2 CSL Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.3.3 CSL Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.3.4 CSL Company Profile and Main Business
        10.3.5 CSL Recent Developments
    10.4 Pfizer
        10.4.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Pfizer Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.4.3 Pfizer Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.4.4 Pfizer Company Profile and Main Business
        10.4.5 Pfizer Recent Developments
    10.5 Grifols
        10.5.1 Grifols Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Grifols Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.5.3 Grifols Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.5.4 Grifols Company Profile and Main Business
        10.5.5 Grifols Recent Developments
    10.6 Biogen
        10.6.1 Biogen Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Biogen Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.6.3 Biogen Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.6.4 Biogen Company Profile and Main Business
        10.6.5 Biogen Recent Developments
    10.7 Octapharma
        10.7.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
        10.7.2 Octapharma Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.7.3 Octapharma Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.7.4 Octapharma Company Profile and Main Business
        10.7.5 Octapharma Recent Developments
    10.8 Novo Nordisk
        10.8.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
        10.8.2 Novo Nordisk Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.8.3 Novo Nordisk Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.8.4 Novo Nordisk Company Profile and Main Business
        10.8.5 Novo Nordisk Recent Developments
    10.9 Greencross
        10.9.1 Greencross Company Information, Head Office, Market Area, and Industry Position
        10.9.2 Greencross Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.9.3 Greencross Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.9.4 Greencross Company Profile and Main Business
        10.9.5 Greencross Recent Developments
    10.10 Kedrion
        10.10.1 Kedrion Company Information, Head Office, Market Area, and Industry Position
        10.10.2 Kedrion Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.10.3 Kedrion Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.10.4 Kedrion Company Profile and Main Business
        10.10.5 Kedrion Recent Developments
    10.11 BPL
        10.11.1 BPL Company Information, Head Office, Market Area, and Industry Position
        10.11.2 BPL Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.11.3 BPL Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.11.4 BPL Company Profile and Main Business
        10.11.5 BPL Recent Developments
    10.12 Hualan Bio
        10.12.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
        10.12.2 Hualan Bio Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.12.3 Hualan Bio Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.12.4 Hualan Bio Company Profile and Main Business
        10.12.5 Hualan Bio Recent Developments
    10.13 RAAS
        10.13.1 RAAS Company Information, Head Office, Market Area, and Industry Position
        10.13.2 RAAS Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.13.3 RAAS Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.13.4 RAAS Company Profile and Main Business
        10.13.5 RAAS Recent Developments
    10.14 Baxalta
        10.14.1 Baxalta Company Information, Head Office, Market Area, and Industry Position
        10.14.2 Baxalta Recombinant Antihemophilic Globulin Models, Specifications, and Application
        10.14.3 Baxalta Recombinant Antihemophilic Globulin Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.14.4 Baxalta Company Profile and Main Business
        10.14.5 Baxalta Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Recombinant Antihemophilic Globulin Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Recombinant Antihemophilic Globulin Market Restraints
 Table 3. Recombinant Antihemophilic Globulin Market Trends
 Table 4. Recombinant Antihemophilic Globulin Industry Policy
 Table 5. Global Recombinant Antihemophilic Globulin Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Recombinant Antihemophilic Globulin Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Recombinant Antihemophilic Globulin Sales Quantity by Company, (2021-2026) & (Units), Ranked Based on Sales in 2025
 Table 8. Global Recombinant Antihemophilic Globulin Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
 Table 9. Global Recombinant Antihemophilic Globulin Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit)
 Table 10. Global Recombinant Antihemophilic Globulin Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 11. Global Recombinant Antihemophilic Globulin Mergers & Acquisitions, Expansion Plans
 Table 12. Global Recombinant Antihemophilic Globulin Manufacturers Product Type
 Table 13. Head Office and Recombinant Antihemophilic Globulin Production Site of Key Manufacturer
 Table 14. Recombinant Antihemophilic Globulin Capacity of Major Manufacturers and Future Plan
 Table 15. Japan Recombinant Antihemophilic Globulin Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 16. Japan Recombinant Antihemophilic Globulin Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 17. Japan Recombinant Antihemophilic Globulin Sales Quantity by Company, (2021-2026) & (Units), Ranked Based on Sales in 2025
 Table 18. Japan Recombinant Antihemophilic Globulin Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
 Table 19. Global Recombinant Antihemophilic Globulin Production & Forecast by Region, 2021 VS 2025 VS 2032, (Units)
 Table 20. Global Recombinant Antihemophilic Globulin Production by Region, 2021-2026, (Units)
 Table 21. Global Recombinant Antihemophilic Globulin Production Forecast by Region, 2027-2032, (Units)
 Table 22. Global Key Players of Recombinant Antihemophilic Globulin Upstream (Raw Materials)
 Table 23. Global Recombinant Antihemophilic Globulin Typical Customers
 Table 24. Recombinant Antihemophilic Globulin Typical Distributors
 Table 25. by Type, Global Recombinant Antihemophilic Globulin Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 26. by Application, Global Recombinant Antihemophilic Globulin Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 27. By Region, Global Recombinant Antihemophilic Globulin Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 28. By Region, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032, US$ Million
 Table 29. By Region, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Table 30. By Country, Global Recombinant Antihemophilic Globulin Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 31. By Country, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032, US$ Million
 Table 32. By Country, Global Recombinant Antihemophilic Globulin Consumption Value Market Share, 2021-2032
 Table 33. By Country, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Table 34. By Country, Global Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2021-2032
 Table 35. Shire (Baxter) Company Information, Head Office, Market Area, and Industry Position
 Table 36. Shire (Baxter) Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 37. Shire (Baxter) Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 38. Shire (Baxter) Company Profile and Main Business
 Table 39. Shire (Baxter) Recent Developments
 Table 40. Bayer Healthcare Company Information, Head Office, Market Area, and Industry Position
 Table 41. Bayer Healthcare Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 42. Bayer Healthcare Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 43. Bayer Healthcare Company Profile and Main Business
 Table 44. Bayer Healthcare Recent Developments
 Table 45. CSL Company Information, Head Office, Market Area, and Industry Position
 Table 46. CSL Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 47. CSL Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 48. CSL Company Profile and Main Business
 Table 49. CSL Recent Developments
 Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position
 Table 51. Pfizer Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 52. Pfizer Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 53. Pfizer Company Profile and Main Business
 Table 54. Pfizer Recent Developments
 Table 55. Grifols Company Information, Head Office, Market Area, and Industry Position
 Table 56. Grifols Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 57. Grifols Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 58. Grifols Company Profile and Main Business
 Table 59. Grifols Recent Developments
 Table 60. Biogen Company Information, Head Office, Market Area, and Industry Position
 Table 61. Biogen Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 62. Biogen Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 63. Biogen Company Profile and Main Business
 Table 64. Biogen Recent Developments
 Table 65. Octapharma Company Information, Head Office, Market Area, and Industry Position
 Table 66. Octapharma Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 67. Octapharma Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 68. Octapharma Company Profile and Main Business
 Table 69. Octapharma Recent Developments
 Table 70. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
 Table 71. Novo Nordisk Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 72. Novo Nordisk Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 73. Novo Nordisk Company Profile and Main Business
 Table 74. Novo Nordisk Recent Developments
 Table 75. Greencross Company Information, Head Office, Market Area, and Industry Position
 Table 76. Greencross Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 77. Greencross Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 78. Greencross Company Profile and Main Business
 Table 79. Greencross Recent Developments
 Table 80. Kedrion Company Information, Head Office, Market Area, and Industry Position
 Table 81. Kedrion Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 82. Kedrion Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 83. Kedrion Company Profile and Main Business
 Table 84. Kedrion Recent Developments
 Table 85. BPL Company Information, Head Office, Market Area, and Industry Position
 Table 86. BPL Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 87. BPL Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 88. BPL Company Profile and Main Business
 Table 89. BPL Recent Developments
 Table 90. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
 Table 91. Hualan Bio Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 92. Hualan Bio Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 93. Hualan Bio Company Profile and Main Business
 Table 94. Hualan Bio Recent Developments
 Table 95. RAAS Company Information, Head Office, Market Area, and Industry Position
 Table 96. RAAS Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 97. RAAS Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 98. RAAS Company Profile and Main Business
 Table 99. RAAS Recent Developments
 Table 100. Baxalta Company Information, Head Office, Market Area, and Industry Position
 Table 101. Baxalta Recombinant Antihemophilic Globulin Models, Specifications, and Application
 Table 102. Baxalta Recombinant Antihemophilic Globulin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
 Table 103. Baxalta Company Profile and Main Business
 Table 104. Baxalta Recent Developments


List of Figures
 Figure 1. Recombinant Antihemophilic Globulin Picture
 Figure 2. Global Recombinant Antihemophilic Globulin Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Global Recombinant Antihemophilic Globulin Sales Quantity, (Units) & (2021-2032)
 Figure 4. Global Recombinant Antihemophilic Globulin Average Selling Price (ASP), (2021-2032) & (US$/Unit)
 Figure 5. Japan Recombinant Antihemophilic Globulin Consumption Value, (US$ million) & (2021-2032)
 Figure 6. Japan Recombinant Antihemophilic Globulin Sales Quantity (Units) & (2021-2032)
 Figure 7. Japan Recombinant Antihemophilic Globulin Average Selling Price (ASP), (US$/Unit) & (2021-2032)
 Figure 8. By Consumption Value, Japan Recombinant Antihemophilic Globulin Market Share of Global, 2021-2032
 Figure 9. By Sales Quantity, Japan Recombinant Antihemophilic Globulin Market Share of Global, 2021-2032
 Figure 10. Global Recombinant Antihemophilic Globulin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 11. Japan Recombinant Antihemophilic Globulin Key Participants, Market Share, 2025
 Figure 12. Global Recombinant Antihemophilic Globulin Capacity, Production and Capacity Utilization, 2021-2032
 Figure 13. Global Recombinant Antihemophilic Globulin Capacity Market Share by Region, 2025 VS 2032
 Figure 14. Global Recombinant Antihemophilic Globulin Production Market Share & Forecast by Region, 2021-2032
 Figure 15. Recombinant Antihemophilic Globulin Industry Chain
 Figure 16. Recombinant Antihemophilic Globulin Procurement Model
 Figure 17. Recombinant Antihemophilic Globulin Sales Model
 Figure 18. Recombinant Antihemophilic Globulin Sales Channels, Direct Sales, and Distribution
 Figure 19. Baikoc
 Figure 20. Afstyla
 Figure 21. Altuviiio
 Figure 22. by Type, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032, US$ Million
 Figure 23. by Type, Global Recombinant Antihemophilic Globulin Consumption Value Market Share, 2021-2032
 Figure 24. by Type, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 25. by Type, Global Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2021-2032
 Figure 26. by Type, Global Recombinant Antihemophilic Globulin Average Selling Price (ASP), 2021-2032, (US$/Unit)
 Figure 27. Clinical Treatment
 Figure 28. Drug Research
 Figure 29. Others
 Figure 30. by Application, Global Recombinant Antihemophilic Globulin Consumption Value, 2021-2032, US$ Million
 Figure 31. by Application, Global Recombinant Antihemophilic Globulin Revenue Market Share, 2021-2032
 Figure 32. by Application, Global Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 33. by Application, Global Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2021-2032
 Figure 34. by Application, Global Recombinant Antihemophilic Globulin Price, 2021-2032, (US$/Unit)
 Figure 35. By Region, Global Recombinant Antihemophilic Globulin Consumption Value Market Share, 2021-2032
 Figure 36. By Region, Global Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2021-2032
 Figure 37. North America Recombinant Antihemophilic Globulin Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 38. By Country, North America Recombinant Antihemophilic Globulin Consumption Value Market Share, 2025
 Figure 39. Europe Recombinant Antihemophilic Globulin Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 40. By Country, Europe Recombinant Antihemophilic Globulin Consumption Value Market Share, 2025
 Figure 41. Asia Pacific Recombinant Antihemophilic Globulin Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 42. By Country/Region, Asia Pacific Recombinant Antihemophilic Globulin Consumption Value Market Share, 2025
 Figure 43. South America Recombinant Antihemophilic Globulin Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 44. By Country, South America Recombinant Antihemophilic Globulin Consumption Value Market Share, 2025
 Figure 45. Middle East & Africa Recombinant Antihemophilic Globulin Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 46. United States Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 47. by Type, United States Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 48. by Application, United States Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 49. Europe Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 50. by Type, Europe Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 51. by Application, Europe Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 52. China Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 53. by Type, China Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 54. by Application, China Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 55. Japan Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 56. by Type, Japan Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 57. by Application, Japan Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 58. South Korea Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 59. by Type, South Korea Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 60. by Application, South Korea Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 61. Southeast Asia Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 62. by Type, Southeast Asia Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 63. by Application, Southeast Asia Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 64. India Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 65. by Type, India Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 66. by Application, India Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 67. Middle East & Africa Recombinant Antihemophilic Globulin Sales Quantity, 2021-2032, (Units)
 Figure 68. by Type, Middle East & Africa Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 69. by Application, Middle East & Africa Recombinant Antihemophilic Globulin Sales Quantity Market Share, 2025 VS 2032
 Figure 70. Research Methodology
 Figure 71. Breakdown of Primary Interviews
 Figure 72. Bottom-up Approaches
 Figure 73. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有